NOAEL Studies
Cosmetic Ingredient
2,5,6-TRIAMINO-4-PYRIMIDINOL SULFATE NOAEL Studies
CAS: 1603-02-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 50 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; H. Schmid, K. Biedermann, H. Luetkemeier, K. Weber, 1995; Subchronic 13-week oral(gavage) toxicity study with 4-OH-2,5,6-triamino-pyrimidine (sulphate) in the rat, RCCProject No. 376255, Test Report, Itingen/CH, October 31, 1995 |
SCCNFP Opinion 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =200 | mg/kg bw | rat | oral | Subchronic | repeated dose toxicity | p.7 |
| SCCNFP Opinion | NOAEL | =1000 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
SCCS Opinion 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.83 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =100 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.13 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/day | human | - | - | NOAEL study | p.18 |
Regulatory source 12 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | dermal absorption | 1000 | mg/kg bw | rat | - | - | dermal absorption | p.11 |
| Regulatory source | repeated dose toxicity | 200 | mg/kg bw | rat | oral | Subchronic | repeated dose toxicity | p.7 |
| Regulatory source | repeated dose toxicity | 200 | mg/kg bw | rabbit | dermal | Sub-chronic | repeated dose toxicity | p.8 |
| Regulatory source | - | 200 | mg/kg bw/day | - | - | - | - | p.13 |
| Regulatory source | - | 1000 | mg/kg bw/day | human | - | - | - | p.18 |
| Regulatory source | - | 1000 | mg/kg bw/day | - | - | - | - | p.19 |
| Regulatory source | dermal absorption | =0.83 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| Regulatory source | dermal absorption | =100 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| Regulatory source | dermal absorption | =200 | mg/kg bw/d | rat | oral | 90-day | dermal absorption | p.20 |
| Regulatory source | genotoxicity | 200 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.14 |
| Regulatory source | repeated dose toxicity | 200 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.13 |
| Regulatory source | repeated dose toxicity | 200 | mg/kg bw/day | rat | oral | subchronic | repeated dose toxicity | p.19 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | T3YK834X4U | UNII | - | - | - | chemical | - |